2-Iodo-LSD
| Clinical data | |
|---|---|
| Other names | Iodo-LSD; Iodine-LSD; IOL; 2-Iodolysergic acid diethylamide; 2-Iodo-N,N-diethyllysergamide; N,N-Diethyl-2-iodo-6-methyl-9,10-didehydroergoline-8β-carboxamide |
| Drug class | Serotonin receptor modulator; Non-hallucinogenic serotonin 5-HT2A receptor modulator |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C20H24IN3O |
| Molar mass | 449.336 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
2-Iodo-LSD (IOL) is a putatively non-hallucinogenic serotonin receptor modulator of the lysergamide family related to 2-bromo-LSD (BOL-148) and lysergic acid diethylamide (LSD). It is the 2-iodo derivative of LSD.